Skip to content
10-K

Annual Report

Cellcyte Genetics Corp.

0001056520-13-000096

← back to feed
Filed
Apr 12, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2012 · Dec 31, 2012 82.33M sh
Operating Cash Flow FY 2012 · Dec 31, 2012 −$6M
Operating Cash Flow FY 2012 · Dec 31, 2011 −$144.3K
Long Term Debt FY 2012 · Dec 31, 2012 $346.42K
Long Term Debt FY 2012 · Dec 31, 2011 $23.2K
Sga Expense FY 2012 · Dec 31, 2012 $2.6M
Sga Expense FY 2012 · Dec 31, 2011 $66.53K
Rd Expense FY 2012 · Dec 31, 2012 $1.3M
Net Income FY 2012 · Dec 31, 2012 −$12.52M
Net Income FY 2012 · Dec 31, 2011 −$359.4K
Shares Diluted FY 2012 · Dec 31, 2011 75.83M sh
Current Liabilities FY 2012 · Dec 31, 2011 $1.26M
Current Assets FY 2012 · Dec 31, 2011 $8.68K
Total Assets FY 2012 · Dec 31, 2011 $39.41K